SHL: Auto Injectors Drive Further Expansion at Taiwan Plant
SHL says the prevalence of injectable drugs will drive auto injectors as it ramps up its Taiwanese production plant.
Archives for February 25, 2013
FDA: Risk-based Immunogenicity Testing will Boost Protein Development
The US FDA says draft guidelines on risk-based immunogenicity testing of protein drugs will encourage the pharma industry to continue development efforts.
Pantarhei Sells Stake in Oral Contraceptive JV
Pantarhei Bioscience has sold in Estetra, its oral contraceptive development JV, to partner Uteron Pharma and will use the proceeds to fund further development.
GOED: Pharma is important for omega-3 but growing slowly
Pharmaceutical omega-3 products are important but will grow more slowly than some expect because of the long timeframe for drug approval, says the chief of the Global Organisation for EPA and DHA Omega-3s (GOED).
West: Proprietary Products Propped by Packaging and Manufacturing
West Pharmaceuticals says it is still intent on shifting to proprietary products following results from its packaging and contract manufacturing businesses.
BASF says Bend Accord Targets Different Chemistries than Dow deal
Bend Research has partnered with its second chemistry major in six months, teaming up with BASF to develop bioavailability-boosting excipients.
Dispatches from Informex
Biopharma CMO Market’s Recent Downturn Could be Short-Lived
Biopharmaceutical CMOs have seen their business slowly shrink as companies seek less volume and smaller batches, but outsourcing is expected to increase over the next three years.
Recipharm Says Developing Trust is Key to Taking on Contracts
Recipharm says taking on a contract started by another CMO is an exercise in building trust and gathering information as rapidly as possible.